Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cumin and ginger extract artificial saliva is a botanical-based oral spray developed by Chulalongkorn University for the management of xerostomia (dry mouth), particularly in patients undergoing hemodialysis. The formulation utilizes the synergistic effects of *Cuminum cyminum* (cumin) and *Zingiber officinale* (ginger) extracts. Ginger is known to act as a sialogogue, stimulating the production of natural saliva through the activation of transient receptor potential vanilloid 1 (TRPV1) receptors and potentially cholinergic pathways. This product functions both as a saliva substitute to lubricate the oral mucosa and as a stimulant to increase endogenous salivary flow, thereby improving oral health and quality of life in patients with dialysis-associated dry mouth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cumin and ginger extract artificial saliva.